Abstract
Methamphetamine (METH) and HIV-1 lead to oxidative stress and their combined effect increases the risk of HIV-associated neurocognitive disorder (HAND), which may be related to the synergistic ferroptotic impairment in microglia. Ferroptosis is a redox imbalance cell damage associated with iron overload that is linked to the pathogenic processes of METH and HIV-1. NRF2 is an antioxidant transcription factor that plays a protective role in METH and HIV-1-induced neurotoxicity, but its mechanism has not been fully elucidated. To explore the role of ferroptosis in METH abuse and HIV-1 infection and the potential role of NRF2 in this process, we conducted METH and HIV-1 Tat exposure models using the BV2 microglia cells. We found that METH and HIV-1 Tat reduced the expression of ferroptotic protein GPX4 and the cell viability and enhanced the expression of P53 and the level of ferrous iron, while the above indices were significantly improved with pretreatment of ferrostatin-1. In addition, NRF2 knockdown accelerated METH and HIV-1 Tat-induced BV2 cell ferroptosis accompanied by decreased expression of SLC7A11. On the contrary, NRF2 stimulation significantly increased the expression of SLC7A11 and attenuated ferroptosis in cells. In summary, our study indicates that METH and HIV-1 Tat synergistically cause BV2 cell ferroptosis, while NRF2 antagonizes BV2 cell ferroptotic damage induced by METH and HIV-1 Tat through regulation of SLC7A11. Overall, this study provides potential therapeutic strategies for the treatment of neurotoxicity caused by METH and HIV-1 Tat, providing a theoretical basis and new targets for the treatment of HIV-infected drug abusers.
Similar content being viewed by others
Availability of Data and Materials
All data and materials could be supplied by the corresponding author upon necessary.
Abbreviations
- DMEM:
-
Dulbecco-modified Eagle medium
- DAPI:
-
4,6-Diamidino-2-phenylindole
- FBS:
-
Fetal bovine serum
- GPX4:
-
Recombinant glutathione peroxidase 4
- HIV-1 Tat:
-
Human immunodeficiency virus-1 transactivator of transcription
- HAND:
-
HIV-1-associated neurocognitive disorders
- KO:
-
Knockout
- METH:
-
Methamphetamine
- NFE2L2/NRF2:
-
Nuclear factor, erythroid-derived 2, like 2
- P53:
-
Cellular tumor antigen P53
- PBS:
-
Phosphate-buffered saline
- SFN:
-
Sulforaphane
- SLC7A11:
-
Solute carrier family 7 member 11
- TBS:
-
Tris-base-buffered saline
- TBST:
-
Tris-HCl buffered saline-Tween 20
References
Abdalkader M, Lampinen R, Kanninen KM, Malm TM, Liddell JR (2018) Targeting Nrf2 to suppress ferroptosis and mitochondrial dysfunction in neurodegeneration. Front Neurosci 12:466. https://doi.org/10.3389/fnins.2018.00466
Buendia I, Michalska P, Navarro E, Gameiro I, Egea J, Leon R (2016) Nrf2-ARE pathway: an emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases. Pharmacol Ther 157:84–104. https://doi.org/10.1016/j.pharmthera.2015.11.003
Chen X, Yu C, Kang R, Tang D (2020) Iron metabolism in ferroptosis. Front Cell Dev Biol 8:590226. https://doi.org/10.3389/fcell.2020.590226
Colonna M, Butovsky O (2017) Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol 35:441–468. https://doi.org/10.1146/annurev-immunol-051116-052358
Cui Y, Zhang Z, Zhou X, Zhao Z, Zhao R, Xu X, Kong X, Ren J, Yao X, Wen Q, Guo F, Gao S, Sun J, Wan Q (2021) Microglia and macrophage exhibit attenuated inflammatory response and ferroptosis resistance after RSL3 stimulation via increasing Nrf2 expression. J Neuroinflammation 18(1):249. https://doi.org/10.1186/s12974-021-02231-x
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B 3rd, Stockwell BR (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5):1060–1072. https://doi.org/10.1016/j.cell.2012.03.042
Dong H, Qiang Z, Chai D, Peng J, Xia Y, Hu R, Jiang H (2020) Nrf2 inhibits ferroptosis and protects against acute lung injury due to intestinal ischemia reperfusion via regulating SLC7A11 and HO-1. Aging (Albany NY) 12(13):12943–12959. https://doi.org/10.18632/aging.103378
Fan Z, Wirth AK, Chen D, Wruck CJ, Rauh M, Buchfelder M, Savaskan N (2017) Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis. Oncogenesis 6(8):e371. https://doi.org/10.1038/oncsis.2017.65
Fattakhov N, Torices S, Stangis M, Park M, Toborek M (2021) Synergistic impairment of the neurovascular unit by HIV-1 infection and methamphetamine use: implications for HIV-1-associated neurocognitive disorders. Viruses 13(9). https://doi.org/10.3390/v13091883
Feng L, Zhao K, Sun L, Yin X, Zhang J, Liu C, Li B (2021a) SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis. J Transl Med 19(1):367. https://doi.org/10.1186/s12967-021-03042-7
Feng Z, Min L, Chen H, Deng W, Tan M, Liu H, Hou J (2021b) Iron overload in the motor cortex induces neuronal ferroptosis following spinal cord injury. Redox Biol 43:101984. https://doi.org/10.1016/j.redox.2021.101984
Friedmann Angeli JP, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ, Herbach N, Aichler M, Walch A, Eggenhofer E, Basavarajappa D, Radmark O, Kobayashi S, Seibt T, Beck H, Neff F, Esposito I, Wanke R, Forster H, Yefremova O, Heinrichmeyer M, Bornkamm GW, Geissler EK, Thomas SB, Stockwell BR, O’Donnell VB, Kagan VE, Schick JA, Conrad M (2014) Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol 16(12):1180–1191. https://doi.org/10.1038/ncb3064
Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, Arama E, Baehrecke EH, Barlev NA, Bazan NG, Bernassola F, Bertrand MJM, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Boya P, Brenner C, Campanella M, Candi E, Carmona-Gutierrez D, Cecconi F, Chan FK, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Cohen GM, Conrad M, Cubillos-Ruiz JR, Czabotar PE, D’Angiolella V, Dawson TM, Dawson VL, De Laurenzi V, De Maria R, Debatin KM, DeBerardinis RJ, Deshmukh M, Di Daniele N, Di Virgilio F, Dixit VM, Dixon SJ, Duckett CS, Dynlacht BD, El-Deiry WS, Elrod JW, Fimia GM, Fulda S, Garcia-Saez AJ, Garg AD, Garrido C, Gavathiotis E, Golstein P, Gottlieb E, Green DR, Greene LA, Gronemeyer H, Gross A, Hajnoczky G, Hardwick JM, Harris IS, Hengartner MO, Hetz C, Ichijo H, Jaattela M, Joseph B, Jost PJ, Juin PP, Kaiser WJ, Karin M, Kaufmann T, Kepp O, Kimchi A, Kitsis RN, Klionsky DJ, Knight RA, Kumar S, Lee SW, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, Lopez-Otin C, Lowe SW, Luedde T, Lugli E, MacFarlane M, Madeo F, Malewicz M, Malorni W, Manic G, Marine JC, Martin SJ, Martinou JC, Medema JP, Mehlen P, Meier P, Melino S, Miao EA, Molkentin JD, Moll UM, Munoz-Pinedo C, Nagata S, Nunez G, Oberst A, Oren M, Overholtzer M, Pagano M, Panaretakis T, Pasparakis M, Penninger JM, Pereira DM, Pervaiz S, Peter ME, Piacentini M, Pinton P, Prehn JHM, Puthalakath H, Rabinovich GA, Rehm M, Rizzuto R, Rodrigues CMP, Rubinsztein DC, Rudel T, Ryan KM, Sayan E, Scorrano L, Shao F, Shi Y, Silke J, Simon HU, Sistigu A, Stockwell BR, Strasser A, Szabadkai G, Tait SWG, Tang D, Tavernarakis N, Thorburn A, Tsujimoto Y, Turk B, Vanden Berghe T, Vandenabeele P, Vander Heiden MG, Villunger A, Virgin HW, Vousden KH, Vucic D, Wagner EF, Walczak H, Wallach D, Wang Y, Wells JA, Wood W, Yuan J, Zakeri Z, Zhivotovsky B, Zitvogel L, Melino G, Kroemer G (2018) Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ 25(3):486–541. https://doi.org/10.1038/s41418-017-0012-4
Gan L, Johnson JA (2014) Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases. Biochim Biophys Acta 8:1208–1218. https://doi.org/10.1016/j.bbadis.2013.12.011
Gao M, Monian P, Pan Q, Zhang W, Xiang J, Jiang X (2016) Ferroptosis is an autophagic cell death process. Cell Res 26(9):1021–1032. https://doi.org/10.1038/cr.2016.95
Granado N, Lastres-Becker I, Ares-Santos S, Oliva I, Martin E, Cuadrado A, Moratalla R (2011) Nrf2 deficiency potentiates methamphetamine-induced dopaminergic axonal damage and gliosis in the striatum. Glia 59(12):1850–1863. https://doi.org/10.1002/glia.21229
Guiney SJ, Adlard PA, Bush AI, Finkelstein DI, Ayton S (2017) Ferroptosis and cell death mechanisms in Parkinson’s disease. Neurochem Int 104:34–48. https://doi.org/10.1016/j.neuint.2017.01.004
Guo D, Huang X, Xiong T, Wang X, Zhang J, Wang Y, Liang J (2022) Molecular mechanisms of programmed cell death in methamphetamine-induced neuronal damage. Front Pharmacol 13:980340 https://doi.org/10.3389/fphar.2022.980340
Hayes JD, Dinkova-Kostova AT (2014) The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci 39(4):199–218. https://doi.org/10.1016/j.tibs.2014.02.002
Ingold I, Berndt C, Schmitt S, Doll S, Poschmann G, Buday K, Roveri A, Peng X, Porto Freitas F, Seibt T, Mehr L, Aichler M, Walch A, Lamp D, Jastroch M, Miyamoto S, Wurst W, Ursini F, Arner ESJ, Fradejas-Villar N, Schweizer U, Zischka H, Friedmann Angeli JP, Conrad M (2018) Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis. Cell 172(3):409–422 e421. https://doi.org/10.1016/j.cell.2017.11.048
Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22(4):266–282. https://doi.org/10.1038/s41580-020-00324-8
Kang R, Kroemer G, Tang D (2019) The tumor suppressor protein p53 and the ferroptosis network. Free Radic Biol Med 133:162–168. https://doi.org/10.1016/j.freeradbiomed.2018.05.074
Lei G, Zhang Y, Koppula P, Liu X, Zhang J, Lin SH, Ajani JA, Xiao Q, Liao Z, Wang H, Gan B (2020) The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res 30(2):146–162. https://doi.org/10.1038/s41422-019-0263-3
Liu J, Xu P, Collins C, Liu H, Zhang J, Keblesh JP, Xiong H (2013) HIV-1 Tat protein increases microglial outward K(+) current and resultant neurotoxic activity. PLoS One 8(5):e64904. https://doi.org/10.1371/journal.pone.0064904
McLaurin KA, Booze RM, Mactutus CF (2019) Diagnostic and prognostic biomarkers for HAND. J Neurovirol 25(5):686–701. https://doi.org/10.1007/s13365-018-0705-6
Mediouni S, Marcondes MC, Miller C, McLaughlin JP, Valente ST (2015) The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders. Front Microbiol 6:1164. https://doi.org/10.3389/fmicb.2015.01164
Mi Y, Gao X, Xu H, Cui Y, Zhang Y, Gou X (2019) The emerging roles of ferroptosis in Huntington’s disease. Neuromolecular Med 21(2):110–119. https://doi.org/10.1007/s12017-018-8518-6
Paul R (2019) Neurocognitive phenotyping of HIV in the era of antiretroviral therapy. Curr HIV/AIDS Rep 16(3):230–235. https://doi.org/10.1007/s11904-019-00426-9
Qie X, Wen D, Guo H, Xu G, Liu S, Shen Q, Liu Y, Zhang W, Cong B, Ma C (2017) Endoplasmic reticulum stress mediates methamphetamine-induced blood-brain barrier damage. Front Pharmacol 8:639. https://doi.org/10.3389/fphar.2017.00639
Reddy PV, Gandhi N, Samikkannu T, Saiyed Z, Agudelo M, Yndart A, Khatavkar P, Nair MP (2012) HIV-1 gp120 induces antioxidant response element-mediated expression in primary astrocytes: role in HIV associated neurocognitive disorder. Neurochem Int 61(5):807–814. https://doi.org/10.1016/j.neuint.2011.06.011
Report WD (2021) United Nations : Office on Drugs and Crime. Retrieved September 28, 2022. www.unodc.org/unodc/en/data-and-analysis/wdr2021.html.
Scutari R, Alteri C, Perno CF, Svicher V, Aquaro S (2017) The role of HIV infection in neurologic injury. Brain Sci 7(4). https://doi.org/10.3390/brainsci7040038
Shin D, Kim EH, Lee J, Roh JL (2018) Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer. Free Radic Biol Med 129:454–462. https://doi.org/10.1016/j.freeradbiomed.2018.10.426
Sigfridsson E, Marangoni M, Hardingham GE, Horsburgh K, Fowler JH (2020) Deficiency of Nrf2 exacerbates white matter damage and microglia/macrophage levels in a mouse model of vascular cognitive impairment. J Neuroinflammation 17(1):367. https://doi.org/10.1186/s12974-020-02038-2
Silverstein PS, Shah A, Gupte R, Liu X, Piepho RW, Kumar S, Kumar A (2011) Methamphetamine toxicity and its implications during HIV-1 infection. J Neurovirol 17(5):401–415. https://doi.org/10.1007/s13365-011-0043-4
Silverstein PS, Shah A, Weemhoff J, Kumar S, Singh DP, Kumar A (2012) HIV-1 gp120 and drugs of abuse: interactions in the central nervous system. Curr HIV Res 10(5):369–383. https://doi.org/10.2174/157016212802138724
Song X, Long D (2020) Nrf2 and ferroptosis: a new research direction for neurodegenerative diseases. Front Neurosci 14:267. https://doi.org/10.3389/fnins.2020.00267
Tang D, Chen X, Kang R, Kroemer G (2021) Ferroptosis: molecular mechanisms and health implications. Cell Res 31(2):107–125. https://doi.org/10.1038/s41422-020-00441-1
Thangaraj A, Chivero ET, Tripathi A, Singh S, Niu F, Guo ML, Pillai P, Periyasamy P, Buch S (2021) HIV TAT-mediated microglial senescence: role of SIRT3-dependent mitochondrial oxidative stress. Redox Biol 40:101843. https://doi.org/10.1016/j.redox.2020.101843
Wang MP, Joshua B, Jin NY, Du SW, Li C (2022) Ferroptosis in viral infection: the unexplored possibility. Acta Pharmacol Sin 43(8):1905–1915. https://doi.org/10.1038/s41401-021-00814-1
Xu E, Liu J, Liu H, Wang X, Xiong H (2017) Role of microglia in methamphetamine-induced neurotoxicity. Int J Physiol Pathophysiol Pharmacol 9(3):84–100
Zeng XF, Li Q, Li J, Wong N, Li Z, Huang J, Yang G, Sham PC, Li SB, Lu G (2018) HIV-1 Tat and methamphetamine co-induced oxidative cellular injury is mitigated by N-acetylcysteine amide (NACA) through rectifying mTOR signaling. Toxicol Lett 299:159–171. https://doi.org/10.1016/j.toxlet.2018.09.009
Funding
This work was supported by the National Nature Science Foundation of China (82160325, 82060382, and 81960340), the Yunnan Applied Basic Research Projects Joint Special Project (202201AY070001-020), and the Basic Research Program of Yunnan Province (202001AT070098).
Author information
Authors and Affiliations
Contributions
We acknowledge Lin S.C., Cheng H., Yang G.M., Wang C., Leung C.K., Zhang S.W., Tan Y., Zhang H.J., Wang H.W., Miao L., Li Y., and Huang Y. Z. for their contribution in literature searching, experimental validation, data analysis, and manuscript writing and acknowledge Li J., Zhang R.L., and Zeng X.F. for supervising the study design and the manuscript edition. All the authors approved the final version for publication.
Corresponding authors
Ethics declarations
Ethical Approval
Not applicable.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Shucheng Lin, Hao Cheng, Genmeng Yang, and Chan Wang have contributed equally to this work.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lin, S., Cheng, H., Yang, G. et al. NRF2 Antagonizes HIV-1 Tat and Methamphetamine-Induced BV2 Cell Ferroptosis by Regulating SLC7A11. Neurotox Res 41, 398–407 (2023). https://doi.org/10.1007/s12640-023-00645-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12640-023-00645-4